Abstract
Immune response and protective efficacy for the combination of four tuberculosis DNA vaccines were evaluated in this study. We obtained 1: 200 antibody titers against Ag85B 21d after mice were vaccinated for the first time by four recombinant eukaryotic expression vectors containing coding sequences for Ag85B, MPT-64, MPT-63 and ESAT-6. The titers of Ag85B were elevated to 1: 102400 after the second injection and decreased to 1: 12800 after the third injection. Antibody titers for MPT-64 and MPT-63 reached 1: 25600 21 d after the first vaccination, and were then decreased following the second and third injections. No antigen-specific antibody titer against ESAT-6 was detected in sera harvested from immunized mice at any time. These DNA vaccines evoked specific IFN-γ responses in the spleens of vaccinated mice as well. When challenged with M. tuberculosis H37Rv, we found that the lungs of the vaccinated mice produced 99.8% less bacterial counts than that of the empty-vector control group and the bacterial counts were also significantly less than that of the BCG group. Histopathological analyses showed that the lungs of vaccinated mice produced no obvious caseation while over 50%-70% of the pulmonary parenchyma tissue produced central caseation in the vector control group. Our results indicated that the combination of four tuberculosis DNA vaccines may generate high levels of immune responses and result in better animal protection.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Wiker, H. G., Harboe, M., The antigen 85 complex: A major secretion product of Mycobacterium tuberculosis, Microbiological Reviews, 1992, 56: 648–661.
Tobias, F., Wit, R. D., Bekelie, S. et al., The Mycobacterium leprae antigen 85 complex gene family: Identification of the genes for the 85A, 85C, and related MPT51 proteins, Infection and Immunity, 1993, 61: 3642–3647.
Roche, P. W., Peake, P. W., Jacobe, H. B. et al., T-cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis, Infection and Immunity, 1994, 62: 5319–5326.
Harth, G., Lee, B. Y., Wang, J. et al., Novel insight into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis, Infection and Immunity, 1996, 64: 3038–3047.
Ulmer, J. B., Liu, M. A., Montgomery, D. L. et al., Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccination, Vaccine, 1997, 15: 792–794.
Denis, O., Tanghe, A., Palfliet, K. et al., Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-Cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv Infection, Infect. Immun., 1998, 66: 1527–1533.
Yamaguchi, R., Matsuo, K., Yamazaki, A. et al., Cloning characterization of the gene for immunogenic protein MPB64 of Mycobacterium bovis BCG, Infection and Immunity, 1989, 57: 283–288.
Oettinge, T., Andersen, A. B., Cloning and B-Cell-epitope mapping of MPT64 from Mycobacterium tuberculosis H37Rv, Infection and Immunity, 1994, 62: 2058–2064.
Oettinger, T., Holm, A., Mtoni, I. M. et al., Mapping of the delayed-type hypersensitivity-inducing epitope of secreted protein MPT64 from Mycobacterium tuberculosis, Infection and Immunity, 1995, 63: 4613–4618.
SΦrensen, A. L., Nagai, S. et al., Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis, Infection and Immunity, 1995, 63: 1710–1717.
Brandt, L., Oettinger, T., Holm, A. et al., Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis, The journal of immunology, 1996, 157: 3527–3533.
Harboe, M., Oettinger, T., Wiker, H. G. et al., Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG, Infection and Immunity, 1996, 64: 16–22.
Manca, C., Lyashchenko, K., Wiker, H. G. et al., Molecular cloning, purification, and serological characterization of MPT-63, a novel antigen secreted by Mycobacterium tuberculosis, Infection and Immunity, 1997, 65: 16–23.
Doolan, D. L., Hoffman, S. L., Multi-gene vaccination against malaria: A multistage, multi-immune response approach, Parasitai Today, 1997, 13: 171–178.
Morris, S., Kelley, C., Howard, A. et al., The immunogenicity of single and combination DNA vaccines against tuberculosis, Vaccine, 2000, 18: 2155–2163.
Cai Hong, Pan Yi, Li Guoli et al., Construction of multivalent DNA vaccines for Mycobacterium tuberculosis and its immunogenicity, Chinese Science Bulletin, 2002, 47(19): 1589–1593.
Pan Yi, Cai Hong, Li Shuxia et al., Combined recombinant DNA vaccine results in significant protection against Mycobacterium tuberculosis, Journal of Biochemistry and Biophysics (in Chinese), 2003, 35(1): 71–76.
Fan Xionglin, Xu Zhikai, Li Yuan et al., Construction and immunogenicity of DNA vaccine encoding secreted from Ag85B protein of Mycobacterium tuberculosis, Chin. J. Tuberc. Respir. Dis. (in Chinese), 2001, 24: 548–550.
You Li, Zhao Yueran, Gao Chunyi et al., Construction of Ag85B DNA vaccine for Mycobacterium tuberculosis and its immunogenicities, Chin. J. Tuberc. Respir. Dis. (in Chinese), 2001, 24: 736–739.
Kamath, A. T., Feng, C. G., Macdonald, M. et al., Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis, Infect. Immun., 1999, 67: 1702–1707.
Agger, E. M., Andersen, P., Tuberculosis subunit vaccine development: On the role of interferon-γ, Vaccine, 2001, 19: 2298–2302.
Tanghe, A., Denis, O., Lambrecht, B. et al., Tuberculosis DNA vaccine encoding Ag85 is immunogenic and protection when administered by intramuscular needle injection but not by epidermal gene gun bombardment, Infect. Immun., 2000, 68: 3854–3860.
Delogu, G., Li, A., Repique, C. et al., DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis, Infect. and Immun., 2002, 70: 292–302.
Mark, A. C., Ann, W., Graham, H. et al., Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis, Infect. and Immun., 2002, 70: 2159–2165.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cai, H., Tian, X., Hu, X. et al. Immunogenicity and protective efficacy study using combination of four tuberculosis DNA vaccines. Sci. China Ser. C.-Life Sci. 46, 495–502 (2003). https://doi.org/10.1360/02yc0121
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1360/02yc0121